Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis ; day:19 ; month:12 ; year:2022 ; pages:1-17
Advances in therapy ; (19.12.2022), 1-17
- Creator
-
Fox, David
To, Tu My
Seetasith, Arpamas
Patel, Anisha M.
Iannaccone, Susan T.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-022-02376-y
- URN
-
urn:nbn:de:101:1-2023030121122942093649
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fox, David
- To, Tu My
- Seetasith, Arpamas
- Patel, Anisha M.
- Iannaccone, Susan T.
- SpringerLink (Online service)
Other Objects (12)
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy
Adherence and Persistence Among Risdiplam-Treated Individuals with Spinal Muscular Atrophy: A Retrospective Claims Analysis
Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy
Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy
Adherence and Persistence Among Risdiplam-Treated Individuals with Spinal Muscular Atrophy: A Retrospective Claims Analysis
Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy
Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Evaluation of Metabolic Effects of Nusinersen in Patients with Spinal Muscular Atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy
Adherence and Persistence Among Risdiplam-Treated Individuals with Spinal Muscular Atrophy: A Retrospective Claims Analysis
Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy